Stonegate capital partners updates coverage on alpha cognition inc. (acog) q1 2025

Dallas, texas--(newsfile corp. - may 19, 2025) - alpha cognition inc. (nasdaq: acog): stonegate capital partners updates their coverage on alpha cognition inc. (nasdaq: acog). alpha cognition began 2025 by launching zunveyl(r) (benzgalantamine) to the u.s. long-term care (ltc) market on march 17, 2025, delivering on its commercialization timeline and budget.

ACOG Ratings Summary

ACOG Quant Ranking